Erectile dysfunction in the elderly: Epidemiology, etiology and approaches to treatment

Journal of Urology

Volumn 169, Issue 6, 2003, Pages 1999-2007

  Seftel, Allen D ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Aged; Aging; Drug therapy; Impotence

Indexed keywords

PHOSPHODIESTERASE; PHOSPHODIESTERASE V; SILDENAFIL; TADALAFIL; UNCLASSIFIED DRUG; VARDENAFIL;

AGE; AGING; COMORBIDITY; DOWN REGULATION; DRUG EFFICACY; DRUG SAFETY; DYSPEPSIA; ELDERLY CARE; ENZYME INHIBITION; ERECTILE DYSFUNCTION; FLUSHING; GENETIC TRANSFECTION; HEADACHE; HUMAN; PENIS; PENIS ERECTION; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SEXUAL FUNCTION; TREATMENT PLANNING;

EID: 0037612211     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000067820.86347.95     Document Type: Review

References (76)

1. McKinlay, J. B.: The worldwide prevalence and epidemiology of erectile dysfunction. Int J Impot Res, suppl., 12: S6, 2000
2. Feldman, H. A., Goldstein, I., Hatzichristou, D. G., Krane, R. J. and McKinlay, J. B.: Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol, 151: 54, 1994
3. Masumori, N., Tsukamoto, T., Kumamoto, Y., Panser, L. A., Rhodes, T., Girman, C. J. et al: Decline of sexual function with age in Japanese men compared with American men - results of two community-based studies. Urology, 54: 335, 1999
4. Marumo, K., Nakashima, J. and Murai, M.: Age-related prevalence of erectile dysfunction in Japan: assessment by the International Index of Erectile Function. Int J Urol, 8: 53, 2001
5. Blanker, M. H., Bosch, J. L., Groeneveld, F. P., Bohnen, A. M., Prins, A., Thomas, S. et al: Erectile and ejaculatory dysfunction in a community-based sample of men 50 to 78 years old: prevalence, concern, and relation to sexual activity. Urology, 57: 763, 2001
6. Braun, M., Wassmer, G., Klotz, T., Reifenrath, B., Mathers, M. and Engelmann, U.: Epidemiology of erectile dysfunction: results of the 'Cologne Male Survey.' Int J Impot Res, 12: 305, 2000
7. Mulligan, T., Retchin, S. M., Chinchilli, V. M. and Betinger, C. B.: The role of aging and chronic disease in sexual dysfunction. J Am Geriatr Soc, 36: 520, 1988
8. Lue, T. F.: Erectile dysfunction. N Engl J Med, 342: 1802, 2000
9. Maggi, M., Filippi, S., Ledda, F., Magini, A. and Forti, G.: Erectile dysfunction: from biochemical pharmacology to advances in medical therapy. Eur J Endocrinol, 143: 143, 2000
10. Uckert, S., Kuthe, A., Stief, C. G. and Jonas, U.: Phosphodiesterase isoenzymes as pharmacological targets in the treatment of male erectile dysfunction. World J Urol, 19: 14, 2001
11. Lin, C. S., Lau, A., Tu, R. and Lue, T. F.: Expression of three isoforms of cGMP-binding cGMP-specific phosphodiesterase (PDE5) in human penile cavernosum. Biochem Biophys Res Commun, 268: 628, 2000
12. Garcia-Reboll, L., Mulhall, J. P. and Goldstein, I.: Drugs for the treatment of impotence. Drugs Aging, 11: 140, 1997
13. Margolese, H. C.: The male menopause and mood: testosterone decline and depression in the aging male - is there a link? J Geriatr Psychiatry Neurol, 13: 93, 2000
14. Kaiser, F. E., Viosca, S. P., Morley, J. E., Mooradian, A. D., Davis, S. S. and Korenman, S. G.: Impotence and aging: clinical and hormonal factors. J Am Geriatr Soc, 36: 511, 1988
15. Schiavi, R. C., Schreiner-Engel, P., White, D. and Mandeli, J.: The relationship between pituitary-gonadal function and sexual behavior in healthy aging men. Psychsom Med, 53: 363, 1991
16. Nehra, A.: Treatment of endocrinologic male sexual dysfunction. Mayo Clin Proc, suppl., 75: S40, 2000
17. Davidson, J. M., Kwan, M. and Greenleaf, W. J.: Hormonal replacement and sexuality in men. Clin Endocrinol Metab, 11: 599, 1982
18. Akkus, E., Carrier, S., Baba, K., Hsu, G.-L., Padma-Nathan, H., Nunes, L. et al: Structural alterations in the tunica albuginea of the penis: impact of Peyronie's disease, aging and impotence. Br J Urol, 79: 47, 1997
19. Moreland, R. B.: Pathophysiology of erectile dysfunction: the contributions of trabecular structure to function and the role of functional antagonism. Int J Impot Res, suppl., 12: S39, 2000
20. Vanegas, J. P., Raviv, G., Kiss, R., Petein, M., Louis, L., Danguy, A. et al: Intracavernous collagen analysis in impotence. Acta Urol Belg, 64: 7, 1996
21. Lin, J. S., Lin, Y. M., Chow, N. H., Wang, S. T. and Sun, Y. N.: Novel image analysis of corpus cavernous tissue in impotent men. Urology, 55: 252, 2000
22. Rowland, D. L., Greenleaf, W., Mas, M., Myers, L. and Davidson, J. M.: Penile and finger sensory thresholds in young, aging, and diabetic males. Arch Sex Behav, 18: 1, 1989
23. Carrier, S., Nagaraju, P., Morgan, D. M., Baba, K., Nunes, L. and Lue, T. F.: Age decreases nitric oxide synthase-containing nerve fibers in the rat penis. J Urol, 157: 1088, 1997
24. Warburton, A. L. and Santer, R. M.: Sympathetic and sensory innervation of the urinary tract in young adult and aged rats: a semi-quantitative histochemical and immunohistochemical study. Histochem J, 26: 127, 1994
25. Amenta, F., Cavallotti, C., De Rossi, M., Ferrante, F. and Geppetti, P.: Vasoactive intestinal polypeptide levels and distribution in the penis of old rats. J Neural Transm, 70: 137, 1987
26. Garban, H., Vernet, D., Freedman, A., Rajfer, J. and Gonzalez-Cadavid, N.: Effect of aging on nitric oxide-mediated penile erection in rats. Am J Physiol, 268: H467, 1995
27. Andrew, P. J. and Mayer, B.: Enzymatic function of nitric oxide synthases. Cardiovasc Res, 43: 521, 1999
28. Hickey, M. J.: Role of inducible nitric oxide synthase in the regulation of leucocyte recruitment. Clin Sci, 100: 1, 2001
29. Rajasekaran, M., Mondal, D., Agrawal, K., Chen, I.-L., Hellstrom, W. and Sikka, S.: Ex vivo expression of nitric oxide synthase isoforms (eNOS/iNOS) and calmodulin in human penile cavernosal cells. J Urol, 160: 2210, 1998
30. Ferrini, M., Magee, T. R., Vernet, D., Rajfer, J. and Gonzalez-Cadavid, N. F.: Aging-related expression of inducible nitric oxide synthase and markers of tissue damage in the rat penis. Biol Reprod, 64: 974, 2001
31. Haas, C. A., Seftel, A. D., Razmjouei, K., Ganz, M. B., Hampel, N. and Ferguson, K.: Erectile dysfunction in aging: upregulation of endothelial nitric oxide synthase. Urology, 51: 516, 1998
32. Melman, A. and Christ, G. J.: Integrative erectile biology. The effects of age and disease on gap junctions and ion channels and their potential value to the treatment of erectile dysfunction. Urol Clin North Am, 28: 217, 2001
33. Jiann, D. B., Seftel, A. D., Fogarty, J., Hampel, N., Cruz, W., Pomerantz, J. et al: Age-related increase in an advanced glycation end product in penile tissue. World J Urol, 13: 369, 1995
34. Vaziri, N. D. and Wang, X. Q.: cGMP-mediated negative feedback regulation of endothelial nitric oxide synthase expression by nitric oxide. Hypertension, 34: 1237, 1999
35. Wimalawansa, S. J.: Age-related changes in tissue contents of immunoreactive calcitonin gene-related peptide. Aging, 4: 211, 1992
36. Chung, W. S., Park, Y. Y. and Kwon, S. W.: The impact of aging on penile hemodynamics in normal responders to pharmacological injection: a Doppler sonographic study. J Urol, 157: 2129, 1997
37. Wandell, P. E. and Brorsson, B.: Assessing sexual functioning in patients with chronic disorders by using a generic health related quality of life questionnaire. Qual Life Res, 9: 1081, 2000
38. Toprakci, M., Ozmen, D., Mutaf, I., Turgan, N., Parildar, Z., Habif, S. et al: Age-associated changes in nitric oxide metabolites nitrite and nitrate. Int J Clin Lab Res, 30: 83, 2000
39. Paniagua, O. A., Bryant, M. B. and Panza, J. A.: Role of endothelial nitric oxide in shear stress-induced vasodilation of human microvasculature: diminished activity in hypertensive and hypercholesterolemic patients. Circulation, 103: 1752, 2001
40. Weber, M. A.: Hypertension in the aging patient: new imperatives, new options. Am J Geriatr Cardiol, 9: 12, 2000
41. Chew, K. K., Earle, C. M., Stuckey, B. G., Jamrozik, K. and Keogh, E. J.: Erectile dysfunction in general medicine practice: prevalence and clinical correlates. Int J Impot Res, 12: 41, 2000
42. Johannes, C. B., Araujo, A. B., Feldman, H. A., Derby, C. A., Kleinman, K. P. and McKinlay, J. B.: Incidence of erectile dysfunction in men 40 to 69 years old: longitudinal results from the Massachusetts Male Aging Study. J Urol, 163: 460, 2000
43. Parazzini, F., Menchini Fabris, F., Bortolotti, A., Calabro, A., Chatenoud, L., Colli, E. et al: Frequency and determinants of erectile dysfunction in Italy. Eur Urol, 37: 43, 2000
44. Martin-Morales, A., Sanchez-Cruz, J. J., Saenz de Tejada, I., Rodriguez-Vela, L., Jiminez-Cruz, J. F. and Burgos-Rodriguez, R.: Prevalence and independent risk factors for erectile dysfunction in Spain: results of the Epidemiologia de la Disfunction Erectil Masculina Study. J Urol, 166: 569, 2001
45. Greenstein, A., Chen, J., Miller, H., Matzkin, H., Villa, Y. and Braf, Z.: Does severity of ischemic coronary disease correlate with erectile function? Int J Impot Res, 9: 123, 1997
46. Kawanishi, Y., Lee, K. S., Kimura, K., Koizumi, T., Nakatsuji, H., Kojima, K. et al: Screening of ischemic heart disease with cavernous artery blood flow in erectile dysfunctional patients. Int J Impot Res, 13: 100, 2001
47. Jaffe, A., Chen, Y., Kisch, E. S., Fischel, B., Alon, M. and Stern, N.: Erectile dysfunction in hypertensive subjects: assessment of potential determinants. Hypertension, 28: 859, 1996
48. Klahr, S.: The role of nitric oxide in hypertension and renal disease progression. Nephrol Dial Transplant, suppl., 16: 60, 2001
49. Heine, R. J.: Current therapeutic options in type 2 diabetes. Eur J Clin Invest, suppl., 29: 17, 1999
50. Romeo, J. H., Seftel, A. D., Madhun, Z. T. and Aron, D. C.: Sexual function in men with diabetes type 2: association with glycemic control. J Urol, 163: 788, 2000
51. Seftel, A. D., Vaziri, N. D., Ni, Z., Razmjouei, K., Fogarty, J., Hampel, N. et al: Advanced glycation end products in human penis: elevation in diabetic tissue, site of deposition, and possible effect through iNOS or eNOS. Urology, 50: 1016, 1997
52. Baynes, J. W.: The role of AGEs is aging: causation or correlation. Exp Gerontol, 36: 1527, 2001
53. Boyle, P., McGinn, R., Maisonneuve, P. and La Vecchia, C.: Epidemiology of benign prostatic hyperplasia: present knowledge and studies needed. Eur Urol, suppl., 20: 3, 1991
54. Namasivayam, S., Minhas, S., Brooke, J., Joyce, A. D., Prescott, S. and Eardley, I.: The evaluation of sexual function in men presenting with symptomatic benign prostatic hyperplasia. Br J Urol, 82: 842, 1998
55. Green, J. S., Holden, S. T., Bose, P., George, D. P. and Bowsher, W. G.: An investigation into the relationship between prostate size, peak urinary flow rate and male erectile dysfunction. Int J Impot Res, 13: 322, 2001
56. Palsson, S. and Skoog, I.: The epidemiology of affective disorders in the elderly: a review. Int Clin Psychopharmacol, suppl., 12: S3, 1997
57. Araujo, A. B., Durante, R., Feldman, H. A., Goldstein, I. and McKinlay, J. B.: The relationship between depressive symptoms and male erectile dysfunction: cross-sectional results from the Massachusetts Male Aging Study. Psychosom Med, 60: 458, 1998
58. Wespes, E. and Schulman, C. C.: Male andropause: myth, reality, and treatment. Int J Impot Res, suppl., 14: S93, 2002
59. Padma-Nathan, H.: Minimally invasive therapy for erectile dysfunction: intracavernosal, oral, transdermal/transglanular, and intraurethral approaches. In: Topics in Clinical Urology: Diagnosis and Management of Male Sexual Dysfunction. Edited by J. J. Mulcahy. Tokyo: Igaku-Shoin, pp. 182-185, 1999
60. Finelli, A., Hirshberg, E. D. and Radomski, S. B.: The treatment choice of elderly patients with erectile dysfunction. Geriatr Nephrol Urol, 8: 15, 1998
61. Kunelius, P. and Lukkarinen, O.: Intracavernous self-injection of prostaglandin E1 in the treatment of erectile dysfunction. Int J Impot Res, 11: 21, 1999
62. Padma-Nathan, H. and Giuliano, F.: Oral drug therapy for erectile dysfunction. Urol Clin North Am, 28: 321, 2001
63. Padma-Nathan, H., McMurray, J. G., Pullman, W. E., Whitaker, J. S., Saoud, J. B., Ferguson, K. M. et al: On-demand IC351 (Cialis) enhances erectile function in patients with erectile dysfunction. Int J Impot Res, 13: 2, 2001
64. Pryor, J. L. and Redmon, B.: New therapies and delivery mechanisms for treatment of erectile dysfunction. Int J Impot Res, suppl., 12: S158, 2000
65. Rendell, M. S., Rajfer, J., Wicker, P. A. and Smith, M. D.: Sildenafil for treatment of erectile dysfunction in men with diabetes: a randomized controlled trial. Sildenafil Diabetes Study Group. JAMA, 281: 421, 1999
66. Wagner, G., Montorsi, F., Auerbach, S. and Collins, M.: Sildenafil citrate (VIAGRA) improves erectile function in elderly patients with erectile dysfunction: a subgroup analysis. J Gerontol A Biol Sci Med Sci, 56: M113, 2001
67. Rosen, R. C., Riley, A., Wagner, G., Osterloh, I. H., Kirkpatrick, J. and Mishra, A.: The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology, 49: 822, 1997
68. Kloner, R. A., Brown, M., Prisant, L. M. and Collins, M.: Effect of sildenafil in patients with erectile dysfunction taking antihypertensive therapy. Sildenafil Study Group. Am J Hypertens, 14: 70, 2001
69. Conti, C. R., Pepine, C. J. and Sweeney, M.: Efficacy and safety of sildenafil citrate in the treatment of erectile dysfunction in patients with ischemic heart disease. Am J Cardiol, suppl., 83: 29C, 1999
70. Price, D.: Sildenafil citrate (Viagra) efficacy in the treatment of erectile dysfunction in patients with common concomitant conditions. Sildenafil Study Group. Int J Clin Pract, suppl., 102: 21, 1999
71. Martinez-Jabaloyas, J. M., Gil-Salom, M., Villamon-Fort, R., Pastor-Hernández, F., Martinez-Garcia, R. and Garcia-Sisamin, F.: Prognostic factors for response to sildenafil in patients with erectile dysfunction. Eur Urol, 40: 641, 2001
72. Brock, G. B., McMahon, C. G., Chen, K. K., Costigan, T., Shen, W., Watkins, V. et al: Efficacy and safety of tadalafil for the treatment of erectile dysfunction: results of integrated analyses. J Urol, 168: 1332, 2002
73. Porst, H., Rosen, R., Padma-Nathan, H., Goldstein, I., Giuliano, F., Ulbrich, E. et al: The efficacy and tolerability of vardenafil, a new, oral, selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction: the first at-home clinical trial. Int J Impot Res, 13: 192, 2001
74. Kass, D. A., Shapiro, E. P., Kawaguchi, M., Capriotti, A. R., Scuteri, A., deGroof, R. C. et al: Improved arterial compliance by a novel advanced glycation end-product crosslink breaker. Circulation, 104: 1464, 2001
75. Champion, H. C., Bivalacqua, T. J., Hyman, A. L., Ignarro, L. J., Hellstrom, W. J. and Kadowitz, P. J.: Gene transfer of endothelial nitric oxide synthase to the penis augments erectile responses in the aged rat. Proc Natl Acad Sci USA, 96: 11648, 1999
76. Bivalacqua, T. J., Champion, H. C., Abdel-Mageed, A. B., Kadowitz, P. J. and Hellstrom, W. J.: Gene transfer or preprocalcitonin gene-related peptide restores erectile function in the aged rat. Biol Reprod, 65: 1371, 2001